- Home
- QRVO vs CORT Comparison
QRVO vs CORT Comparison
Compare QRVO & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QRVO
- CORT
- Stock Information
- Founded
- QRVO 1957
- CORT 1998
- Country
- QRVO United States
- CORT United States
- Employees
- QRVO N/A
- CORT N/A
- Industry
- QRVO Semiconductors
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- QRVO Technology
- CORT Health Care
- Exchange
- QRVO Nasdaq
- CORT Nasdaq
- Market Cap
- QRVO 7.1B
- CORT 7.5B
- IPO Year
- QRVO 1997
- CORT N/A
- Fundamental
- Price
- QRVO $86.08
- CORT $69.31
- Analyst Decision
- QRVO Hold
- CORT Strong Buy
- Analyst Count
- QRVO 19
- CORT 4
- Target Price
- QRVO $89.56
- CORT $142.00
- AVG Volume (30 Days)
- QRVO 1.9M
- CORT 1.6M
- Earning Date
- QRVO 07-29-2025
- CORT 07-28-2025
- Dividend Yield
- QRVO N/A
- CORT N/A
- EPS Growth
- QRVO N/A
- CORT 8.36
- EPS
- QRVO 0.58
- CORT 1.14
- Revenue
- QRVO $3,718,971,000.00
- CORT $685,446,000.00
- Revenue This Year
- QRVO $0.51
- CORT $35.83
- Revenue Next Year
- QRVO $5.08
- CORT $35.24
- P/E Ratio
- QRVO $148.59
- CORT $60.73
- Revenue Growth
- QRVO N/A
- CORT 30.93
- 52 Week Low
- QRVO $49.46
- CORT $29.42
- 52 Week High
- QRVO $130.99
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- QRVO 71.63
- CORT 41.95
- Support Level
- QRVO $82.41
- CORT $72.48
- Resistance Level
- QRVO $81.50
- CORT $75.95
- Average True Range (ATR)
- QRVO 1.86
- CORT 2.69
- MACD
- QRVO 0.20
- CORT -0.10
- Stochastic Oscillator
- QRVO 84.99
- CORT 0.37
About QRVO Qorvo Inc.
Qorvo represents the combined entity of RF Micro Devices and TriQuint Semiconductor, which merged in January 2015. The company specializes in radio frequency filters, power amplifiers, and front-end modules used in many of the world's most advanced smartphones. Qorvo also has a suite of products sold into a variety of nonsmartphone end markets, such as wireless base stations, cable TV and networking equipment, and infrastructure and military applications.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.